Selective Cysteinyl Leukotriene CysLT1 Receptor Antagonist • Rx

Montelukast Sodium

Brand Reference: Singulair

Medically Reviewed by Dr. Devon Caldwell, DO, MPH (NPI #1568063758)
78.60%
Patient “Worth It”
26 verified logs
$5.20
Lowest Monthly Cash

Montelukast Sodium Clinical & Real-World Cost Fact Matrix

Metric Verified Benchmark Source
Montelukast Sodium RxNorm Concept ID 88249 U.S. National Library of Medicine (RxNorm)
CMS NADAC Pharmacy Acquisition Unit Cost $0.0410 / unit CMS Medicaid NADAC Weekly Feed
Walk-In Chain Pharmacy Cash Average $32.00 / mo CMS NADAC + U.S. Retail Markup Index
Mark Cuban Cost Plus Wholesale Price $5.20 / mo Cost Plus Drugs Wholesale Feed
Community Mean Out-of-Pocket Paid $6.40 / mo 26 Zero-PHI Verified Patient Logs
INSTANT PRESCRIPTION & CASH ROUTING

Verified Online Prescribers & Wholesale Pharmacies for Montelukast Sodium

DotMD Club Members get $29 flat-rate script renewals →
Mark Cuban Cost Plus Drugs (Wholesale Pharmacy)
Requires an existing doctor prescription. Need a script? Pair with a $29 DotMD Club TeleMed consult.
$5.20/mo
Wholesale Cash Price
View Wholesale Rx →
AgelessRx Geroprotective Telehealth (Online Doctor Consult + Delivery)
Asynchronous physician review included • Ships in ~3 days • Rx included in monthly tier
$ 65.00
All-In Monthly
Start Online Visit →

Montelukast Sodium Clinical Pharmacology & DailyMed Monograph

RxCUI 88249 • NDC 00378-5710-93

Binds bronchial and nasal mucosal CysLT1 receptors with high selectivity to block leukotriene D4-mediated airway edema, eosinophil recruitment, and exercise-induced bronchoconstriction.

CMS National Average Drug Acquisition Cost (NADAC) tracking places Montelukast Sodium (Singulair, RxCUI 88249) at $0.0410 per unit, whereas walk-in chain pharmacies bill cash patients an average of $32.00 monthly—creating a 84% ($26.80/mo) wholesale arbitrage spread down to $5.20.

Systemic exposure to Montelukast Sodium reflects 64% oral absorption kinetics and hepatic cyp2c8 (major), cyp3a4, and cyp2c9; 86% biliary fecal clearance, sustaining receptor engagement across a 2.7–5.5 hours half-life window (2–4 hours airway leukotriene blockade response profile).

Dosing protocols (10 mg PO once daily in evening) balance efficacy (78.60% patient satisfaction across 26 logs) against vivid dreams / sleep disturbance (18% of reports), headache (8% of reports), with strict avoidance in prior montelukast neuropsychiatric mood/sleep disturbance.

Half-Life
2.7–5.5 hours
Bioavailability
64% oral
Metabolism & Clearance
Hepatic CYP2C8 (major), CYP3A4, and CYP2C9; 86% biliary fecal clearance
Clinical Onset
2–4 hours airway leukotriene blockade

Standard Adult Titration & Dosages

10 mg PO once daily in evening

Absolute & Relative Contraindications

  • Prior montelukast neuropsychiatric mood/sleep disturbance

Logged Side-Effect Incidence (26 Reports)

Vivid dreams / sleep disturbance 18%
Headache 8%

Montelukast Sodium Patient Dosage Logs & Out-of-Pocket Cost Ledger

Across 26 verified cash-pay logs, Montelukast Sodium achieves a 78.60% Worth-It rating with out-of-pocket spend averaging $6.40/mo versus $32.00/mo walk-in retail.

15-Second Anonymous Micro-Log (Zero-PHI Architecture)

Share your real dosage and monthly out-of-pocket cost—no account, email, or IP stored.

Effectiveness: 5/5 • Worth It Dosage: 10 mg PO once daily in evening • Paid: $4.58/mo via Cost Plus Drugs
Vivid dreams / sleep disturbance

Switched to Cost Plus Drugs at 10 mg PO once daily in evening for Montelukast Sodium; monthly out-of-pocket dropped to $4.58 compared with $32.00 retail.

Effectiveness: 5/5 • Worth It Dosage: 10 mg PO once daily in evening • Paid: $5.30/mo via Cost Plus Drugs

Completed 10 weeks on Montelukast Sodium (10 mg PO once daily in evening). Zero notable side effects on steady dosing.

Effectiveness: 4/5 • Not Worth It Dosage: 10 mg PO once daily in evening • Paid: $6.03/mo via Local Pharmacy
Vivid dreams / sleep disturbance

Consistent biomarker response on 10 mg PO once daily in evening Montelukast Sodium sourced via Local Pharmacy ($6.03/mo cash pay without insurance prior authorization).